[go: up one dir, main page]

KR910018033A - 악티노바실루스 플루로뉴모니아(Actinobacillus pleuropneumoniae) 서브유니트 백신 - Google Patents

악티노바실루스 플루로뉴모니아(Actinobacillus pleuropneumoniae) 서브유니트 백신 Download PDF

Info

Publication number
KR910018033A
KR910018033A KR1019910006414A KR910006414A KR910018033A KR 910018033 A KR910018033 A KR 910018033A KR 1019910006414 A KR1019910006414 A KR 1019910006414A KR 910006414 A KR910006414 A KR 910006414A KR 910018033 A KR910018033 A KR 910018033A
Authority
KR
South Korea
Prior art keywords
vaccine
cells
sds
pluronomymoniae
page
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
KR1019910006414A
Other languages
English (en)
Other versions
KR100196208B1 (ko
Inventor
프란시스크스 반덴 보쉬 요하네스
Original Assignee
에프. 지. 엠. 헤르만스 씨 호우크
악조 엔. 브이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에프. 지. 엠. 헤르만스 씨 호우크, 악조 엔. 브이 filed Critical 에프. 지. 엠. 헤르만스 씨 호우크
Publication of KR910018033A publication Critical patent/KR910018033A/ko
Application granted granted Critical
Publication of KR100196208B1 publication Critical patent/KR100196208B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

내용 없음

Description

악티노바실루스 플루로뉴모니아(Actinobacillus pleuropneumoniae) 서브유니트 백신
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 42KD가 농축된 OMP 제제물을 건재시킨 SDS/PAHE겔을 조사한 것이다,제2도는 회복기 돼지의 혈청을 사용한 프로테이나제-K OMP제제물의 웨스턴 불로팅이다. 레인1 및 4:조악한OMP;레인2,3와 6;정제; 레인1-3: 대조용 처리된것;레인4-6: 플테이나제-K처리된 것, 제3도는 백신접종후의 혈청을 사용한 박테리아 용해물의 웨스틴 블로팅이다.

Claims (10)

  1. 악티노바실루스 플루로뉴모니아(Actinobacillus pleuropneumoniae) 감염에 대해 돼지를 보호하기 위한 백신 조성물에 있어서, 이 조성물은 에이, 플루로뉴모니아세포가 거의 없으며 ①SDS-PAGE에서 약 105KD인 악티노바실루스 플루로뉴모니아(Actinobacillus pleuropneumoniae)의 헤로라이신 및, ②SDS-PAGE 에서 약 120KD인 에이. 플루로뉴모니아의 대식세포독소로 구성된 군에서 선택된 적어도 하나의 독소와 SDS-PAGE에서 약42KD인 주요한 우성항원 단백질을 갖고 있는 에이, 플루로뉴모니아의 외부막 단백질 제제로 부터 얻어진것을 특징으로하는 백신 조성물.
  2. 제1항에 있어서, 상기 백신은 상기 외부막 단백질 제제, 상기 헤모라이신 및 상기 대식세포 독소로부터 얻어진 것을 특징으로 하는 백신.
  3. 제1항 내지 제2항에 있어서, 상기 백신은 혈청형1,5a,5b,9,10 또는 11세포의 헤모라이신으로부터 얻어진 것을 특징으로 하는 백신.
  4. 제1항 내지 제3항 중 어느 한 항에 있어서, 상기 백신은 혈청형2,3,4,6또는 8세포의 대식세포독소로부터 얻어진 것을 특징으로 하는 백신.
  5. 제2항에 있어서, 상기 백신은 혈청형 1세포의 외부막 단백질 제제, 혈청형5b세포의 헤모라이신 및 혈청형 2세포의 대식세포로부터 얻어진 것을 특징으로 하는 백신.
  6. 제1항 내지 제5항중 어느 한항에 있어서, 돼지의 다른 병원균의 항원성 물질을 추가로 포함하는 것을 특징으로 하는 백신.
  7. 제6항에 있어서, 상기 돼지 병원균은 위공견병 비루스 또는 인플루엔지 비루스인 것을 특징으로 하는 백신.
  8. 제1항 내지 제7항중 어느 한항에 있어서, 상기 백신은 보조제를 포함하는 것을 특징으로 하는 백신.
  9. 악티노바실루스 플루로뉴모니아 세포가 거의 없으며, 상기 에이, 플루로뉴모니아 감염에 대해 돼지를 보호하기 위한 백신을 제조하는 방법에 있어서, SDS-PAGE에서 측정된 약42KD인 주요한 우성항원 단백질 성분을 갖고 있는 에이. 플루로뉴모니아의 외부막 단백질과 ①SDS-PAGE에서 약 105KD인 에이. 플루로뉴모니아의 헤모라이신 및 ②SDS-PAGE 에서 약 12KD인 에이.플루로뉴모니아의 대식세포독소로 유래된 에이. 플루로뉴모니아 항원성 물질을 면역 활성을 갖고 있는 조성물에 혼합하는 것을 특징으로 하는 방법.
  10. 제1항 내지 제8항중 어느 한 항에 의한 백신을 동물에 투여하는 것을 특징으로 하는 에이. 플루로뉴모니아 감염에 대해 돼지를 보호하기 위한 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019910006414A 1990-04-20 1991-04-19 악티노바실루스 플루로뉴모니아 서브 유니트 백신 Expired - Fee Related KR100196208B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP90.200989.3 1990-04-20
EP90200989 1990-04-20

Publications (2)

Publication Number Publication Date
KR910018033A true KR910018033A (ko) 1991-11-30
KR100196208B1 KR100196208B1 (ko) 1999-06-15

Family

ID=8204998

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910006414A Expired - Fee Related KR100196208B1 (ko) 1990-04-20 1991-04-19 악티노바실루스 플루로뉴모니아 서브 유니트 백신

Country Status (14)

Country Link
US (1) US5648081A (ko)
EP (1) EP0453024B1 (ko)
JP (1) JP3240063B2 (ko)
KR (1) KR100196208B1 (ko)
CN (1) CN1055024C (ko)
AU (1) AU634879B2 (ko)
CA (1) CA2040544C (ko)
DE (1) DE69110082T2 (ko)
DK (1) DK0453024T3 (ko)
ES (1) ES2075325T3 (ko)
GR (1) GR3017160T3 (ko)
HU (1) HU211031B (ko)
NZ (1) NZ237867A (ko)
ZA (1) ZA912796B (ko)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101491792B1 (ko) * 2013-09-10 2015-02-13 대한민국 신규한 액티노바실러스 플로르뉴모니아 혈청형 5번 균주, 이를 포함하는 진단용 조성물 및 백신 조성물
KR101491803B1 (ko) * 2013-09-10 2015-02-16 대한민국 신규한 액티노바실러스 플로르뉴모니아 혈청형 2번 균주, 이를 포함하는 진단용 조성물 및 백신 조성물

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06503351A (ja) * 1990-12-19 1994-04-14 ファイザー・インコーポレイテッド ワクチン、特にブタ胸膜肺炎ワクチンの免疫強化
US5994525A (en) 1991-06-28 1999-11-30 Kamp; Elbarte Margriet Nucleic acid encoding Actinobacillus pleuropneumoniae cytolytic proteins
US5417971A (en) * 1991-10-22 1995-05-23 University Of Saskatchewan Vaccines for Actinobacillus pleuropneumoniae
AU4114893A (en) * 1992-04-27 1993-11-29 Michigan State University Method for producing a bacterial vaccine and novel vaccines produced thereby
US6656477B1 (en) * 1992-07-28 2003-12-02 Board Of Trustees Of Michigan State University 43 Kd protein vaccine and method for the production thereof
CA2170839A1 (en) * 1995-03-01 1996-09-02 Janet Macinnes Bacterial preparations, method for producing same, and their use as vaccines
US5925354A (en) 1995-11-30 1999-07-20 Michigan State University Riboflavin mutants as vaccines against Actinobacillus pleuropneumoniae
US6342231B1 (en) 1998-07-01 2002-01-29 Akzo Nobel N.V. Haemophilus parasuis vaccine and diagnostic
US6713071B1 (en) 1998-10-22 2004-03-30 Pfizer Inc. Proteins from actinobacillus pleuropneumoniae
TWI224107B (en) * 1998-10-22 2004-11-21 Pfizer Prod Inc Novel proteins from actinobacillus pleuropneumoniae
KR100372278B1 (ko) * 2000-03-03 2003-02-17 주식회사 한국미생물연구소 돼지 호흡기용 혼합백신
AU2003213233B2 (en) * 2002-02-25 2009-02-05 U.S. Army Medical Research And Materiel Command Method of making CS6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections
TWI461529B (zh) * 2008-11-27 2014-11-21 Intervet Int Bv 產製ＲＴＸ毒素ＡｐｘＩ之方法
TWI392737B (zh) * 2008-11-27 2013-04-11 Intervet Int Bv 產製ＲＴＸ毒素ＡｐｘＩ或ＡｐｘIII 之方法
TWI548746B (zh) 2009-08-06 2016-09-11 英特威特國際股份有限公司 防備豬胸膜肺炎之疫苗及製備該疫苗之方法
CN102058880B (zh) * 2010-10-13 2012-11-21 青岛易邦生物工程有限公司 猪传染性胸膜肺炎三价灭活疫苗的生产方法
ES2416154B1 (es) 2011-11-09 2015-04-01 Laboratorios Hipra, S.A. Cepa viva atenuada de Actinobacillus pleuropneumoniae
CN104502581B (zh) * 2014-12-07 2016-05-04 青岛易邦生物工程有限公司 一种猪传染性胸膜肺炎抗体检测用抗原及制备方法
KR101818901B1 (ko) 2016-08-26 2018-01-16 우진 비앤지 주식회사 돼지흉막폐렴균의 재조합 ApxIA, ApxIIA, ApxIIIA toxin의 N 또는 C 말단 분자 및 불활화 돼지흉막폐렴균을 이용한 돼지 흉막폐렴 백신 조성물
EP3689373A1 (en) 2019-01-30 2020-08-05 IDT Biologika GmbH Inactivated apxia, apxiia and apxiiia toxins
GB202011902D0 (en) 2020-07-30 2020-09-16 Imperial College Innovations Ltd Antinobacillus pleuropneumoniae vaccines

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK138379A (da) * 1979-04-04 1980-10-05 Nordisk Droge & Kemikalie Vaccine imod pleuropneumonia (ondartet lungesyge) hos svin dens anvendelse samt fremgangsmaade og substat til dyrkning specielt aerob fermentering af mikroorganismen haemophilus pleuropneumoniae
US5047237A (en) * 1985-09-06 1991-09-10 Prutech Research And Development Partnership Attenuated pseudorabies virus having a deletion of at least a portion of a gene encoding an antigenic, nonessential protein, vaccine containing same and methods of identifying animals vaccinated with the vaccine
NL8802007A (nl) * 1988-08-12 1990-03-01 Centraal Diergeneeskundig Inst Vaccin, geschikt voor de profylaxe respectievelijk de bestrijding van de door haemophilus pleuropneumoniae teweeggebrachte ziekte bij varkens alsmede werkwijze voor het winnen van extracellulair eiwitachtig materiaal van haemophilus pleuropneumonie, geschikt voor toepassing in dergelijke vaccins.
US5641653A (en) * 1989-10-31 1997-06-24 The Texas A&M University System DNA encoding Actinobacillus pleuropneumoniae hemolysin

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101491792B1 (ko) * 2013-09-10 2015-02-13 대한민국 신규한 액티노바실러스 플로르뉴모니아 혈청형 5번 균주, 이를 포함하는 진단용 조성물 및 백신 조성물
KR101491803B1 (ko) * 2013-09-10 2015-02-16 대한민국 신규한 액티노바실러스 플로르뉴모니아 혈청형 2번 균주, 이를 포함하는 진단용 조성물 및 백신 조성물

Also Published As

Publication number Publication date
CN1056428A (zh) 1991-11-27
CN1055024C (zh) 2000-08-02
HUT61489A (en) 1993-01-28
EP0453024B1 (en) 1995-05-31
EP0453024A1 (en) 1991-10-23
HU211031B (en) 1995-09-28
CA2040544C (en) 2002-10-22
CA2040544A1 (en) 1991-10-21
JPH04225924A (ja) 1992-08-14
DK0453024T3 (da) 1995-10-16
GR3017160T3 (en) 1995-11-30
JP3240063B2 (ja) 2001-12-17
ZA912796B (en) 1992-01-29
KR100196208B1 (ko) 1999-06-15
AU634879B2 (en) 1993-03-04
AU7519291A (en) 1991-11-21
US5648081A (en) 1997-07-15
DE69110082D1 (de) 1995-07-06
NZ237867A (en) 1992-11-25
ES2075325T3 (es) 1995-10-01
DE69110082T2 (de) 1995-11-09
HU911303D0 (en) 1991-10-28

Similar Documents

Publication Publication Date Title
KR910018033A (ko) 악티노바실루스 플루로뉴모니아(Actinobacillus pleuropneumoniae) 서브유니트 백신
ES8704350A1 (es) Procedimiento para la preparacion de un conjugado bacteriano
CA2082155A1 (en) Swine pneumonia vaccine and method of preparation
DE3585185D1 (de) Immunogene konjugate der lt-b enterotoxinuntereinheit von e. coli und kapselige polymere.
PT1204699E (pt) Composicoes para peliculas a base de pululano
IL101348A0 (en) Polyethylene glycol protein conjugates,their preparation and pharmaceutical compositions containing them
BR9811475A (pt) Conjugados imunogênicos compreendendo uma porina meningocóccica de grupo b e um polissacarìdeo de h. influenzae
LV10203A (lv) Panemiens inficesanas ar AIDS noteiksanai olbaltumvielu kompozicija test-komplekts
DK0957935T3 (da) Chlamydia-vacciner og immunogene præparater indeholdende et ydre membran-antigen samt fremgangsmåde til fremstilling deraf
ATE350057T1 (de) Impfstoffzusammesetzung
JP2001523729A5 (ko)
IL106968A0 (en) Potentiation of immunogenic response
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
AU1813701A (en) Interleukin-1 muteins useful as vaccine adjuvants
FI972054A0 (fi) Immunogeenisiä koostumuksia
KR920006004A (ko) 헤모필루스 파라갈리나룸 (Haemophilus paragallinaum)왁찐
EP0230264A3 (en) Pharmaceutical composition for nasal application, process for its preparation and its use
CA2114611A1 (en) Method of reversing immunosuppression in vaccines
NZ239281A (en) Antigenic hiv conjugate, vaccine and pharmaceutical composition
IT1116840B (it) Perfezionamento nelle composizioni farmaceutiche contenenti prostaglandina
AR000555A1 (es) Uso de composiciones anabolicas para la masa osea en base a cantidades efectivas no toxicas del ácido Ä3-(n,n-dimetilamino)-1-hidroxipropilidenoÜbisfosfonico o la sal monosodica u otra sal farmacéuticamente aceptable del mismo
CA2273922A1 (en) Novel saponin compositions and uses thereof
WO2002036160A3 (es) Método de obtención de estructuras antigénicas que potencian la reactividad cruzada específica
SU1538305A1 (ru) Ассоциированная вакцина против лептоспироза и парвовирусной инфекции свиней
CA2133108A1 (en) Pasteurella haemolytica type a-1 bacterin-toxoid vaccine

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R14-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 11

FPAY Annual fee payment

Payment date: 20100209

Year of fee payment: 12

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 12

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20110220

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20110220